Mack Gene
Gain Therapeutics, Inc. · CEO
Mack Gene is listed in public filings as director, officer: CEO, President. This Mack Gene insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Gain Therapeutics, Inc. (GANX). Investors use Mack Gene's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $372k200k shares | Grant / ExerciseMar 24, 2026 | $372.0K200k shares | $1.86 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $458k200k shares | Grant / ExerciseMar 20, 2025 | $458.0K200k shares | $2.29 | -- | |
| $662k271.3k shares | Grant / ExerciseJan 6, 2025 | $662.0K271.3k shares | $2.44 | -- | |
| $15k14.4k shares | BuyAug 9, 2024 | $14.5K14.4k shares | $1.01 | -- |